| The Estates At Rush City Llc | |
| 650 Bremer Avenue South, Rush City, Minnesota 55069 | |
| (320) 358-4765 | |
| Name | The Estates At Rush City Llc |
|---|---|
| Location | 650 Bremer Avenue South, Rush City, Minnesota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 45 |
| Occupancy Rate | 74.44% |
| Medicare ID (CCN) | 245348 |
| Legal Business Name | Estates At Rush City Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1770021248 |
| Organization Name | ESTATES AT RUSH CITY LLC |
| Address | 650 S Bremer Ave, Rush City, MN 55069 |
| Phone Number | 320-358-4765 |
News Archive
Today, on World Lung Day, the American Thoracic Society is united with members of the Forum of International Respiratory Societies and WLD partner organizations to advocate for respiratory health globally and call on policymakers to ensure that everyone has access to the services they need to improve their lung health.
An international team led by Weill Cornell Medical College investigators has illuminated the precise molecular steps that enable pancreatic cancer to spread to the liver - the event that makes the most common form of the disease lethal. By understanding this process, investigators say their discovery can lead to targeted treatments that delay metastasis, and could offer clinicians a new biomarker to test for the earliest signs of pancreatic cancer.
Although there have been achievements in the battle against cancer, including a decrease in the rate of death and new diagnoses, cancer remains one of the leading causes of death in the U.S., with a need for continued improvement in the areas of prevention, detection and treatment, according to a commentary in the March 17 issue of JAMA, a theme issue on cancer.
Pulmatrix, Inc., previously known as Ruthigen, Inc., today announced the completion of its previously announced merger, effective June 15, 2015, and the closing of a private placement generating aggregate gross proceeds of $10.0 million. Participants in the private placement included pre-merger investors in Pulmatrix such as funds affiliated with 5AM Ventures, ARCH Venture Partners and Polaris Partners, as well as funds affiliated with Altitude Life Science Ventures.
Two spin-out companies from the London School of Hygiene & Tropical Medicine (LSHTM) have merged to form a new company that will improve the detection and control of infectious diseases.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Today, on World Lung Day, the American Thoracic Society is united with members of the Forum of International Respiratory Societies and WLD partner organizations to advocate for respiratory health globally and call on policymakers to ensure that everyone has access to the services they need to improve their lung health.
An international team led by Weill Cornell Medical College investigators has illuminated the precise molecular steps that enable pancreatic cancer to spread to the liver - the event that makes the most common form of the disease lethal. By understanding this process, investigators say their discovery can lead to targeted treatments that delay metastasis, and could offer clinicians a new biomarker to test for the earliest signs of pancreatic cancer.
Although there have been achievements in the battle against cancer, including a decrease in the rate of death and new diagnoses, cancer remains one of the leading causes of death in the U.S., with a need for continued improvement in the areas of prevention, detection and treatment, according to a commentary in the March 17 issue of JAMA, a theme issue on cancer.
Pulmatrix, Inc., previously known as Ruthigen, Inc., today announced the completion of its previously announced merger, effective June 15, 2015, and the closing of a private placement generating aggregate gross proceeds of $10.0 million. Participants in the private placement included pre-merger investors in Pulmatrix such as funds affiliated with 5AM Ventures, ARCH Venture Partners and Polaris Partners, as well as funds affiliated with Altitude Life Science Ventures.
Two spin-out companies from the London School of Hygiene & Tropical Medicine (LSHTM) have merged to form a new company that will improve the detection and control of infectious diseases.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 2.22 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 34.21 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.4 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.1 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.2 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.25 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 37.93 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.85 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 17.87 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 10 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 0 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 80.96 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.73 | 82.93 |
News Archive
Today, on World Lung Day, the American Thoracic Society is united with members of the Forum of International Respiratory Societies and WLD partner organizations to advocate for respiratory health globally and call on policymakers to ensure that everyone has access to the services they need to improve their lung health.
An international team led by Weill Cornell Medical College investigators has illuminated the precise molecular steps that enable pancreatic cancer to spread to the liver - the event that makes the most common form of the disease lethal. By understanding this process, investigators say their discovery can lead to targeted treatments that delay metastasis, and could offer clinicians a new biomarker to test for the earliest signs of pancreatic cancer.
Although there have been achievements in the battle against cancer, including a decrease in the rate of death and new diagnoses, cancer remains one of the leading causes of death in the U.S., with a need for continued improvement in the areas of prevention, detection and treatment, according to a commentary in the March 17 issue of JAMA, a theme issue on cancer.
Pulmatrix, Inc., previously known as Ruthigen, Inc., today announced the completion of its previously announced merger, effective June 15, 2015, and the closing of a private placement generating aggregate gross proceeds of $10.0 million. Participants in the private placement included pre-merger investors in Pulmatrix such as funds affiliated with 5AM Ventures, ARCH Venture Partners and Polaris Partners, as well as funds affiliated with Altitude Life Science Ventures.
Two spin-out companies from the London School of Hygiene & Tropical Medicine (LSHTM) have merged to form a new company that will improve the detection and control of infectious diseases.
› Verified 6 days ago
The Estates At Rush City Llc Location: 650 Bremer Avenue South, Rush City, Minnesota 55069 Phone: (320) 358-4765 |